Since 2009, World MS Day is officially marked on the last Wednesday of May with events and campaigns focused on bringing the worldwide multiple sclerosis (MS) community together and raising awareness about the disease.
Life with MS
This World MS Day the theme is Life with MS. About 2.3 million people across the world suffer from MS, one of the most common neurological disorders and causes of disability in young adults, while hundreds of thousands remain undiagnosed. According to the Multiple Sclerosis Foundation, more than 400,000 people in the U.S. have MS with approximately 200 new cases being diagnosed each week.
There are different types of MS including primary progressive MS (PPMS), relapsing MS (RMS), the most common form of the disease, and secondary progressive MS (SPMS).
The multiple sclerosis market represents huge commercial potential. According to information provided by GlobalData, the MS market is slated to grow from $17.2 billion in 2014 to about $20 billion by 2024. While there is no cure for the disease, several treatments are available to manage the disease. Competition in the MS market is intense given the presence of injectable treatments as well as oral disease-modifying therapies. Moreover, several companies are working on bringing new treatments to market with different mechanisms of action which are easy to administer or require less frequent dosing.
Here is a look at some of the key players in the MS market.
Biogen Inc. (BIIB - Free Report) : Cambridge, MA-based Biogen is, perhaps, the most well-known name in the MS space. The companys marketed portfolio includes six MS drugs including oral treatment, Tecfidera. Although Biogen has had its share of challenges with progressive multifocal leukoencephalopathy (PML) being associated with Tysabri as well as Tecfidera, the companys MS franchise brought in sales of $8.8 billion in 2016 and accounts for a major part of total revenues. Biogen is a Zacks Rank #3 (Hold) stock. Biogens shares have declined 13.1% year-to-date (YTD), lagging the Zacks-categorized Medical-Biomedical/Genetics industry which is down 0.3% so far in 2017.
Teva Pharmaceutical Industries Limited (TEVA - Free Report) : Israel-based Teva is also a key player in the MS market. Although well known for its strong position in the generics market, Tevas MS product Copaxone is a key contributor to the companys branded product revenues. The drug generated $4.2 billion in revenues last year though sales would take a hit if generic versions of the 40 mg dose enter the market. Moreover, competition in the MS market has intensified significantly. Meanwhile, Tevas attempts to develop laquinimod have also not met with much success with the experimental MS treatment failing in a study in patients with relapsing-remitting multiple sclerosis (RRMS). Laquinimod is currently in a study for PPMS.
YTD, Teva has lagged the Zacks-categorized Medical-Generic Drugs industry with shares declining 23.3% compared to the industry decline of 7.9%.
Novartis AG (NVS - Free Report) : Swiss pharma giant, Novartis, also has a strong presence in the MS market with drugs like Extavia and Gilenya in its portfolio. Gilenya was the first oral therapy to gain approval for RMS and the first in a new class of compounds called S1P receptor modulators. Gilenya contributed $3.1 billion to the top-line in 2016. Meanwhile, Sandoz, Novartis generic arm, markets Glatopa, a generic version of Tevas Copaxone 20 mg.
Novartis currently has two late-stage MS candidates in its branded product pipeline -- OMB157, an anti-CD20 monoclonal antibody for RMS with pivotal data readout expected in 2019, and BAF312, an oral, second-generation S1P receptor, with regulatory filing in the U.S. for RMS slated for the first half of 2018. Both candidates represent blockbuster potential. Novartis is also working on expanding Gilenyas label.
YTD, Novartis has outperformed the Zacks categorized Large Cap Pharmaceuticals industry with shares gaining 10.6% compared to the industry gain of 9.1%.
Sanofi (SNY - Free Report) : Another player in the MS market is French pharma giant Sanofi which has two MS products in its portfolio -- Aubagio and Lemtrada. The MS franchise delivered sales of 1.7 billion in 2016 and Sanofi is working on life cycle management plans for the products. The companys MS pipeline has an early-stage RMS candidate, GZ402668 (GLD52, anti-CD52 mAb, RMS, phase I). Sanofi has also performed better than the Zacks categorized Large Cap Pharmaceuticals industry with shares soaring 21.3% YTD.
Roche Holding AG (RHHBY - Free Report) : Swiss firm, Roches Ocrevus is a recent entrant in the MS market. Ocrevus, which has blockbuster potential, is the first and only FDA approved medicine for both relapsing and primary progressive forms of MS. However, with an Ocrevus patient being diagnosed with PML, the drugs sales potential could be impacted if the potentially deadly brain infection is directly associated with the drug. According to a Reuters article, the company is currently investigating the case which could be associated with the use of Tysabri prior to Ocrevus. Roche has also outperformed the Zacks categorized Large Cap Pharmaceuticals industry with shares soaring 19.7% YTD.
Biogen, Teva, Novartis and Roche are all Zacks Rank #3 stocks while Sanofi is a Zacks Rank #2 (Buy) stock -- you can see the complete list of todays Zacks #1 Rank (Strong Buy) stocks here. More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs. A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>
Read the original post:
5 Drug Stocks in Focus on World MS Day - May 31, 2017 - Zacks.com - Zacks.com
- Rally for Multiple Sclerosis Treatment Funding - May 7th, 2011 [May 7th, 2011]
- Breakthrough Multiple Sclerosis Treatment? - May 8th, 2011 [May 8th, 2011]
- Multiple Sclerosis Treatment - Mayo Clinic - May 11th, 2011 [May 11th, 2011]
- Tracy Macchia: Controversial MS Treatment - May 14th, 2011 [May 14th, 2011]
- What is Multiple Sclerosis - May 19th, 2011 [May 19th, 2011]
- MS Multiple Sclerosis treatment testimonial from Sanoviv Medical Institute - May 20th, 2011 [May 20th, 2011]
- Patient with progressive ms(paraplegia) Fmr treatment 1/4 - May 22nd, 2011 [May 22nd, 2011]
- New Jersey Multiple Sclerosis Treatment with Chiropractic Care - May 23rd, 2011 [May 23rd, 2011]
- MS Cure - Progression - June 2nd, 2011 [June 2nd, 2011]
- CCSVI UK Multiple Sclerosis Liberation Treatment - June 2nd, 2011 [June 2nd, 2011]
- Stem Cell Therapy MS: Sam Harrell and The Superbowl - June 3rd, 2011 [June 3rd, 2011]
- Holly Huber on Recovery: Stem Cell Therapy for Multiple Sclerosis Community Outreach Dallas, TX 2011 - June 8th, 2011 [June 8th, 2011]
- MS treatment sees early success - June 9th, 2011 [June 9th, 2011]
- CCSVI Possible cure for Multiple sclerosis - June 10th, 2011 [June 10th, 2011]
- MS Cure - Introduction to stem cell bone marrow transplant in Australia - June 11th, 2011 [June 11th, 2011]
- (Multiple Sclerosis Cure) Change Your Thinking? (Multiple Sclerosis Cure) - June 12th, 2011 [June 12th, 2011]
- Essiac cancer treatment herbal tincture, Ms Caisse...from The Secrets of Eden - June 12th, 2011 [June 12th, 2011]
- MS walking treatment breakthrough - June 14th, 2011 [June 14th, 2011]
- multiple sclerosis natural treatment | Kathy Canada Testimonial - June 18th, 2011 [June 18th, 2011]
- CCSVI Surgery India - Liberation Procedure Multiple Sclerosis Treatment in India - June 29th, 2011 [June 29th, 2011]
- XCell-Center MS CCSVI Liberation Angioplasty Treatment Results E.Schuurman 18_01_11 - July 1st, 2011 [July 1st, 2011]
- MS Cure - 7PM Project Carmel Turner MS Stem Cell Treatment - July 9th, 2011 [July 9th, 2011]
- MS Update! Tysabri or Gilenya? - July 10th, 2011 [July 10th, 2011]
- What causes BSE, CJD - July 15th, 2011 [July 15th, 2011]
- Kath Bartlett, MS, LAc Balance Method Acupuncture - July 16th, 2011 [July 16th, 2011]
- MS Cure - 730 report ben leahy carmel turner ms stem cell treatment - July 17th, 2011 [July 17th, 2011]
- CCSVI LIberation Treatment Tokuda - July 18th, 2011 [July 18th, 2011]
- FOX News Interview on the O'Reilly Factor - Treatment of Women in Islam - July 18th, 2011 [July 18th, 2011]
- CCSVI treatment bloopers holy crap - July 18th, 2011 [July 18th, 2011]
- Tarah's CCSVI Venoplasty. Dr McGuckin Explaining procedure findings - July 19th, 2011 [July 19th, 2011]
- Cancer Cure: The One-Minute Cure For Cancer, MS - July 24th, 2011 [July 24th, 2011]
- Not Ready to Cheer CCSVI Trials - July 29th, 2011 [July 29th, 2011]
- New Oral Treatment for MS - July 30th, 2011 [July 30th, 2011]
- 27/07/2011 - MS patients seek controversial treatment - August 1st, 2011 [August 1st, 2011]
- MS Cure - 11 I am still walking - August 5th, 2011 [August 5th, 2011]
- Upcoming Treatments for MS - Pt 1 -MSRA Public Lecture - Dr Suzanne Hodgkinson - August 10th, 2011 [August 10th, 2011]
- Stem Cells for MS Community Outreach: Patient Judi Lecoq - Dallas, TX 2011 - August 18th, 2011 [August 18th, 2011]
- Stem Cell Treatment for Multiple Sclerosis - Community Outreach, San Diego: David Oliver - August 19th, 2011 [August 19th, 2011]
- New Study Tests Possible Treatment for MS - August 25th, 2011 [August 25th, 2011]
- Professor Dimitrios Karussis: Treating MS - August 26th, 2011 [August 26th, 2011]
- walking with MS before CCSVI treatment.wmv - August 27th, 2011 [August 27th, 2011]
- Suzy Cohen Discusses The Liberation Treatment for MS - September 14th, 2011 [September 14th, 2011]
- Multiple Sclerosis MS People - Amazing New Treatment - September 15th, 2011 [September 15th, 2011]
- Multiple Sclerosis Alternative Treatment - September 17th, 2011 [September 17th, 2011]
- CLEAR scoliosis treatment, Dr. Culpepper (MS) - September 22nd, 2011 [September 22nd, 2011]
- Liberation treatment for MS - September 23rd, 2011 [September 23rd, 2011]
- 44b - My Lyme disease and rheumatoid arthritis journey - Miraculous CCSVI treatment for MS sufferers - September 24th, 2011 [September 24th, 2011]
- A Closer Look at Gilenya - The First Oral Treatment for MS - September 28th, 2011 [September 28th, 2011]
- Unequal Treatment Drives Disability Rights Movement - September 28th, 2011 [September 28th, 2011]
- Multiple Sclerosis - The Nebraska Medical Center - September 29th, 2011 [September 29th, 2011]
- Testimonial for CCSVI Treatment Excel Heart Center Mexico -- Tanya Reay - September 30th, 2011 [September 30th, 2011]
- Current thinking on what causes MS - Pt 1 - MSRA Public Lecture -Prof Graeme Stewart - October 2nd, 2011 [October 2nd, 2011]
- Current and emerging therapies in MS - Part 02 (How do these treatments work?) - October 2nd, 2011 [October 2nd, 2011]
- MS Richard Humphries before and after treatment for Multiple Sclerosis with stem cells - October 3rd, 2011 [October 3rd, 2011]
- Matthew - CCSVI and his Liberation Treatment - October 8th, 2011 [October 8th, 2011]
- Multiple Sclerosis - Myelin Repair - Video - October 14th, 2011 [October 14th, 2011]
- MS Auto Immune vs CCSVI Treatment Simple Pictures by Berukoff - Video - October 23rd, 2011 [October 23rd, 2011]
- New Promising Treatment for Those Living with Multiple Sclerosis - Video - October 29th, 2011 [October 29th, 2011]
- Stem cells to treat MS - Pt 2 - MSRA Public Lecture - A/Prof Richard Burt - Video - October 30th, 2011 [October 30th, 2011]
- New hope for treating multiple sclerosis - Video - October 31st, 2011 [October 31st, 2011]
- CCSVI Multiple sclerosis Breakthrough/cure - Video - October 31st, 2011 [October 31st, 2011]
- Inhuman Treatment of Wheelchair bound Multiple Sclerosis Patient in Canadian Care Home - Video - November 9th, 2011 [November 9th, 2011]
- MS treatment movie Cells4health.mp4 - Video - November 10th, 2011 [November 10th, 2011]
- Racing to the Cure for MS: Myelin Repair Foundation Celebrates MS Awareness Week - Video - November 12th, 2011 [November 12th, 2011]
- [Symptoms of Multiple Sclerosis] - Video - November 12th, 2011 [November 12th, 2011]
- Multiple Sclerosis Treated with Adult Stem Cells - Video - November 13th, 2011 [November 13th, 2011]
- Stem cells to treat MS - Pt 1 - MSRA Public Lecture - A/Prof Richard Burt - Video - November 16th, 2011 [November 16th, 2011]
- Multiple Sclerosis A Natural Treatment - Video - November 16th, 2011 [November 16th, 2011]
- My MS and Stem Cell Treatment - Video - November 16th, 2011 [November 16th, 2011]
- CCSVI Liberation News Reports - Video - November 20th, 2011 [November 20th, 2011]
- Stem Cells for MS Community Outreach: Patient Sam Harrell - Dallas, TX 2011 - Video - November 21st, 2011 [November 21st, 2011]
- Arthur S13 E2-1 - The Silent Treatment - Video - November 27th, 2011 [November 27th, 2011]
- Holly Huber on Recovery: Stem Cell Therapy for Multiple Sclerosis Community Outreach San Diego CA - Video - December 3rd, 2011 [December 3rd, 2011]
- CCSVI - Video - December 3rd, 2011 [December 3rd, 2011]
- My Sister's Experience with Liberation Treatment for Multiple Sclerosis PART 2/2 - Video - December 5th, 2011 [December 5th, 2011]
- Multiple Sclerosis -- Treatment LDN story - Video - December 7th, 2011 [December 7th, 2011]
- ABC News - Multiple Sclerosis effectively treated by a new acoustic medical device. - Video - December 9th, 2011 [December 9th, 2011]
- MS Patient After Stem Cell Therapy - Video - December 10th, 2011 [December 10th, 2011]
- Multiple Sclerosis - Video - December 12th, 2011 [December 12th, 2011]
- Journey of Connective Tissue, Autoimmune disease, steroid treatment updates. - Video - December 22nd, 2011 [December 22nd, 2011]